Frazier Life Sciences X, L.P.

Holdings History for NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value EUR0.12 per share (NAMS)

Symbol: NAMS on Nasdaq
Investment type: Equity / Ordinary Shares, nominal value EUR0.12 per share
Latest Disclosed Shares Owned: 8,623,939 shares
Security Ownership %: 7.7%

Frazier Life Sciences Public Fund, L.P. ownership in NewAmsterdam Pharma Co N.V. Ordinary Shares, nominal value EUR0.12 per share (NAMS)

04 Nov 2025 - Frazier Life Sciences Public Fund, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8,623,939 shares of NewAmsterdam Pharma Co N.V. Ordinary Shares, nominal value EUR0.12 per share (NAMS). This represents 7.7% ownership of the company. In their previous filing dated 20 Aug 2025, Frazier Life Sciences X, L.P. had reported owning 7,327,937 shares, indicating an increase of +18%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Frazier Life Sciences Public Fund, L.P.	7.7%	+17%	$245,264,825	8,623,939	+1,296,002	+18%	$28.44	13D/A	01 Nov 2025	04 Nov 2025, 17:23
Frazier Life Sciences X, L.P.	6.5%		$164,365,627	7,327,937			$22.43	13D/A	18 Aug 2025	20 Aug 2025, 17:28